Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,429 | 136,204 | 33,017 | N/A | N/A |
| Marketable Securities | 7,233 | N/A | N/A | N/A | N/A |
| TOTAL | $113,535 | $140,552 | $33,994 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 890 | 815 | N/A | N/A | N/A |
| Other Non-Current Assets | 299 | 101 | 180 | 0 | 0 |
| TOTAL | $1,189 | $916 | $180 | $N/A | $N/A |
| Total Assets | $114,724 | $141,468 | $34,174 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,243 | 920 | 603 | 0 | 0 |
| Accrued Expenses | 3,937 | 2,227 | 340 | N/A | N/A |
| TOTAL | $5,180 | $3,147 | $943 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,180 | $3,147 | $943 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,063 | 24,034 | N/A | N/A | N/A |
| Retained earnings | -66,298 | -32,959 | -12,452 | N/A | N/A |
| Other shareholders' equity | 6 | 0 | 43,921 | 0 | 0 |
| TOTAL | $109,544 | $138,321 | $33,231 | $N/A | $N/A |
| Total Liabilities And Equity | $114,724 | $141,468 | $34,174 | $0 | $0 |